"Are we getting to the point where it's safe to gene-edit babies?"
This commentary argues that despite recent advances in CRISPR base editing showing safer results in human embryos, it is still not safe enough to allow gene-editing babies. The author contends that while base editing reduces unintended mutations, it must work perfectly in every cell of an embryo, a standard not yet achieved.